Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Celera Corporation patents


Recent patent applications related to Celera Corporation. Celera Corporation is listed as an Agent/Assignee. Note: Celera Corporation may have other listings under different names/spellings. We're not affiliated with Celera Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Celera Corporation-related inventors


Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof

The present invention provides compositions and methods based on genetic polymorphisms that are associated with autoinflammatory diseases such as psoriasis. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.. ... Celera Corporation

Cancer targets and uses thereof

Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“cat”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using cat. ... Celera Corporation

Colon disease targets and uses thereof

The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (ccat) and antibodies binds to ccat. ... Celera Corporation

Methods and compositions for treating and diagnosing diseases

Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (cat) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of cat, and methods for screening agents that modulate cat level or activity in vivo or in vitro.. ... Celera Corporation

Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment

This invention relates to nucleotide polymorphisms in the human apo(a) gene and to the use of apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.. . ... Celera Corporation

Pancreatic cancer targets and uses thereof

The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (pcat) and antibodies binds to pcat. ... Celera Corporation

Lung cancer markers and uses thereof

Methods and compositions are provided for assessing (e.g., diagnosing), treating, and preventing diseases, especially cancer, and particular lung cancer, using lung cancer markers (lcm). Individual lcm and panels comprising multiple lcm are provided for these and other uses. ... Celera Corporation

Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof

The present invention is based on the discovery of genetic polymorphisms that are associated with rheumatoid arthritis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.. ... Celera Corporation

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.. ... Celera Corporation

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.. ... Celera Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Celera Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Celera Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###